$RDAR News: Raadr Inc., Doing Business as Telvantis,

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
147
$RDAR News: Raadr Inc., Doing Business as Telvantis, Accelerates With $32M+ in Revenue Across February and March; Business Plan Relaunch Gaining Momentum

Raadr Inc., Doing Business as Telvantis, Accelerates With $32M+ in Revenue Across February and March; Business Plan Relaunch Gaining Momentum


NEW YORK - April 21, 2025 (NEWMEDIAWIRE) - Raadr Inc., doing business as Telvantis (OTC: RDAR) ("Telvantis" or the "Company", a U.S.-based technology-driven telecommunications and enterprise solutions provider, today announced approximately $32 million in revenue across February and March 2025, confirming strong execution of its business relaunch and growth strategy.

With $12.5 million in February and $19.6 million in March, the companys revenue trajectory continues to accelerate, validating Telvantiss position as an emerging force in the telecom technology space. This milestone comes on the heels of Telvantis completing its legacy debt remediation and officially entering the next phase of scalable operations.

This isnt hypothetical. This is verified revenue, and it proves our platform is delivering real results at scale, said Daniel Contreras, CEO of Telvantis. Weve spent the last few months quietly rebuilding our foundation, and now were turning up the volume. Were executing. Were accelerating. And were just getting started.

The Companys Gross Margin totaled approximately $1 million over these two months and generated a slight positive operating profit before financing costs. The Companys complete financial statements will be included in the Companys quarterly report, which is due May 15, 2025.

This is a first important step towards the delivery of our ambitious plan, and there is more work to be done to drive profitability over the rest of the year. We will stay on course and focus on both gross profit margin improvement and cost savings, added Contreras.

Note that all mentioned numbers are unaudited.

Key Revenue Drivers

Enterprise Messaging (CPaaS): Telvantis powers secure A2P messaging and verification services across fintech, healthcare, and ecommerce clients worldwide.
Telecom Carrier Optimization: Revenue from high-volume routing and traffic management across Telvantis's 300+ global carrier relationships.
Global Expansion: Strong international delivery capacity and new B2B relationships fueled growth across both months.
A New Phase of Scalable Growth

These numbers signal that Telvantiss restructuring and transition efforts in 2024 have culminated in a functional, revenue-generating and profitable model that is now scaling quickly.

February and March prove our plan is working, added Daniel Gilcher, CFO of Telvantis. Were entering Q2 with stronger systems, growing relationships, and increasing market traction. Now that weve addressed our past obligations, our focus is squarely on intelligent expansion and shareholder value.

What Comes Next

Q1 2025 Revenue Summary: A full report on first-quarter performance will follow shortly.
Acquisition Strategy: With the foundation in place, Telvantis is now actively evaluating accretive acquisition targets to accelerate market share and service offerings.
Uplisting & Transparency: Audits are underway as the company continues to prepare for potential uplisting and enhanced corporate governance.
About Telvantis

Raadr, Inc., now doing business as Telvantis (OTC: RDAR), is a U.S.-based telecommunications company delivering advanced solutions to operators, enterprises, and network providers worldwide. Through its recent acquisitions of operations in the U.S. and Ireland, Telvantis has strategically expanded its portfolio to encompass cutting-edge 5G technologies, cloud-based communications platforms, and enterprise-grade services. This expansion, combined with a forward-thinking approach, positions Telvantis for accelerated growth and market leadership in the evolving telecommunications landscape.

Forward-looking statements

This press release contains forward-looking statements that involve risks and uncertainties. These statements reflect the Company's current expectations regarding future events and are based on management's beliefs and assumptions. Actual results could differ materially from those projected due to various factors, including market conditions, competition, and the successful integration of acquired operations. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by law.

Investor Relations Contact

Raadr Inc. (doing business as Telvantis)
1680 Michigan Avenue, Suite 700
Miami Beach, FL 33139
Email: ir@telvantis.com
Website: www.telvantis.com
Twitter/X: @Telvantis
LinkedIn: Telvantis

View the original release on www.newmediawire.com


News Source: Telvantis Inc.

21.04.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

Language: English
Company: Telvantis Inc.
United States
ISIN: US74979T2078
EQS News ID: 2121004

Raadr Inc. (RDAR) Stock Research Links

RDAR Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 361

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 232

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 507

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 241

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 62

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 223

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 175

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 121

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 57

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 233

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading

Top 5 Most Recently Viewed Articles

Key Indicators Highlighting Inflation Risks in the US Economy

Updated Category News Views 405

Understanding Inflation Trends and Risks Monitoring inflation trends has become increasingly important in the current economic climate, where the Consumer Price Index (CPI) had previously surged to 9.0%. Now, with inflation levels around 2.7%, many are left observing potential shifts in macroeconomic conditions. As government policies shift, especially with new leadership...

Continue Reading
Cornish Metals Expands Share Capital with New Stock Options

Updated Category News Views 133

Cornish Metals Strengthens Its Financial Position Vancouver-based Cornish Metals Inc. (TSX-V: CUSN, LSE: CUSN) is excited to announce a significant move to bolster its financial stature. The company, known for its focus on mineral exploration and development, specifically its permitted South Crofty tin project, has exercised stock options resulting in the issuance of...

Continue Reading
Jackson Physician Search Celebrates 10 Years of Excellence in Healthcare

Updated Category News Views 149

Jackson Physician Search Celebrated as a Premier Workplace Jackson Physician Search has achieved an impressive milestone by earning No. 2 ranking among medium-sized companies and eighth overall in the esteemed healthcare sector, in the annual Modern Healthcare awards for best places to work. This announcement follows the company's remarkable ten consecutive years on this...

Continue Reading
CAMARA Introduces Revolutionary AI-Driven Network Solutions

Updated Category News Views 128

Revolutionizing AI Applications with CAMARA and MCP CAMARA, an open-source community project, is leading the charge in bridging artificial intelligence (AI) with telecommunication networks via modern APIs. Their innovative approach is outlined in a newly released white paper asserting the capabilities of their Model Context Protocol (MCP) combined with network APIs. The...

Continue Reading
Cohen & Steers Infrastructure Fund: Key Distribution Insights

Updated Category News Views 178

Cohen & Steers Infrastructure Fund Overview Cohen & Steers Infrastructure Fund, Inc. (NASDAQ: UTF) provides valuable investment options focusing on infrastructure. As an influential player in capital assets, the Fund aims to meet the needs of investors looking for sustainable income and growth. Understanding the sources of distribution is essential for shareholders...

Continue Reading